Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

EXPLAINED: 13 | Vintage Vibes

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022

Benzinga

Piper Sandler Maintains Neutral Rating for Pacific Biosciences: Here's What You Need To Know

Piper Sandler has decided to maintain its Neutral rating of Pacific Biosciences (NASDAQ:PACB) and lower its price target from $13.00 to $6.00. Shares of Pacific Biosciences are trading down 2.74% over the last 24 hours, at $5.68 per share.

Benzinga

10 Biggest Price Target Changes For Thursday

Wells Fargo cut the price target on Ford Motor Company (NYSE: F) from $24 to $12. Ford shares fell 2.8% to $12.47 in pre-market trading.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Piper Sandler Maintains Overweight Rating for Beauty Health: Here's What You Need To Know

Piper Sandler has decided to maintain its Overweight rating of Beauty Health (NASDAQ:SKIN) and lower its price target from $26.00 to $24.00. Shares of Beauty Health are trading down 0.76% over the last 24 hours, at $12.40 per share.

Benzinga

Why These Analysts Cut Unity Software Price Target By 50%

Shares of Unity Software Inc (NYSE: U) tanked more than 30% after the company reported a wider-than-expected net loss for the first quarter and issued weak revenue guidance.

Benzinga

What Are Whales Doing With Palantir Technologies

Someone with a lot of money to spend has taken a bearish stance on Palantir Technologies (NYSE:PLTR). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022

Upgrades

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022

Upgrades

Benzinga

'Still A Second-Half Story': Twilio Analysts React To Mixed Q1 Earnings

Twilio Inc (NYSE: TWLO) shares dropped 2.7% on Thursday after the company reported conservative second-quarter guidance.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

Benzinga

Piper Sandler Maintains Overweight Rating for eBay: Here's What You Need To Know

Piper Sandler has decided to maintain its Overweight rating of eBay (NASDAQ:EBAY) and lower its price target from $68.00 to $63.00. Shares of eBay are trading down 9.28% over the last 24 hours, at $49.37 per share. A move to $63.00 would account for a 27.61% increase from the current…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2022

Upgrades

Benzinga

Masimo Posts Better Than Expected Q1 Earnings Despite 'Unexpected' Supply Chain Issues

Masimo Corp's (NASDAQ:MASI) Q1 revenue increased 1.7% Y/Y (+3.2% on a constant currency basis) to $304.2 million, beating the consensus of $303.83 million. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 75,700 in Q1 of 2022. The adjusted operating margin remained unchanged at 22.9%. The company reported…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022

Upgrades

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Piper Sandler Downgrades Kellogg And Tyson Foods

Consumers are cutting back spending, even on basic goods, due to elevated levels of inflation, according to Piper Sandler.

Benzinga

Piper Sandler Maintains Overweight Rating for ZoomInfo Technologies: Here's What You Need To Know

Piper Sandler has decided to maintain its Overweight rating of ZoomInfo Technologies (NASDAQ:ZI) and lower its price target from $75.00 to $65.00. Shares of ZoomInfo Technologies are trading up 3.7% over the last 24 hours, at $51.02 per share.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

Upgrades

Benzinga

JPMorgan Chase Whale Trades For May 02

Someone with a lot of money to spend has taken a bearish stance on JPMorgan Chase (NYSE:JPM). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Piper Sandler Downgrades Territorial Bancorp: Here's What You Need To Know

Piper Sandler downgraded its rating of Territorial Bancorp (NASDAQ:TBNK) to Underweight with a price target of $24.00, changing its price target from $27.00 to $24.00. Shares of Territorial Bancorp are trading up 0.13% over the last 24 hours, at $22.74 per share.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022

Upgrades

Benzinga

Why Are Accolade Shares Down Over 40% Today

Accolade Inc (NASDAQ:ACCD) shares plunged almost 50% after disappointing Q4 FY22 earnings and FY23 guidance. Q4 FY22 revenue increased 58% Y/Y to $93.8 million, beating the consensus of $91.57 million. The company reported a wider net loss of $(34.56) million compared to $(4.73) million a year ago. EPS loss came at $(0.51)…

Benzinga

Matterport Analyst Slashes Price Target By 30%: Spatial Data Company Stares At Triple Near-Term Risks

Matterport Inc (NASDAQ: MTTR) shares are receding on Friday after an analyst at Piper Sandler tempered his expectations concerning the spatial data company.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 29, 2022

Upgrades

Benzinga

Recap: Piper Sandler Q1 Earnings

Piper Sandler (NYSE:PIPR) reported its Q1 earnings results on Friday, April 29, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Piper Sandler Maintains Overweight Rating for Amgen: Here's What You Need To Know

Piper Sandler has decided to maintain its Overweight rating of Amgen (NASDAQ:AMGN) and raise its price target from $255.00 to $260.00. Shares of Amgen are trading down 5.5% over the last 24 hours, at $235.12 per share. A move to $260.00 would account for a 10.58% increase from the current…

1 … 12 13 14 15

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.